Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa

Teleflex Resorbable Magnesium Scaffold demonstrates sustained long-term safety in four-year study

Teleflex (NYSE:TFX) announced positive four-year follow-up data from its First-in-Human BIOMAG-I clinical trial, reinforcing the long-term safety and performance stability of its third-generation Freesolve Resorbable Magnesium Scaffold.

Read more: Teleflex Resorbable Magnesium Scaffold demonstrates sustained long-term safety in four-year study
Grafa

RedHill's opaganib receives FDA rare pediatric disease designation for childhood cancer

RedHill Biopharma (NASDAQ:RDHL) announced that the U.S. Food and Drug Administration has granted rare pediatric disease designation to its investigational asset, opaganib, for the treatment of neuroblastoma, a type of cancer that primarily affects infants and young children.

Read more: RedHill's opaganib receives FDA rare pediatric disease designation for childhood cancer
Grafa
Retail

Nathan’s Famous revenue rises to $162M as beef costs pinch profits

Nathan’s Famous (NASDAQ:NATH) reported higher top-line revenue for fiscal year 2026, driven by growth in its foodservice and franchise segments, even as surging input costs chipped away at overall profit margins ahead of its planned private ownership transition.

Read more: Nathan’s Famous revenue rises to $162M as beef costs pinch profits